Flavio Zuccarino

ORCID: 0000-0002-3446-3770
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Congenital Diaphragmatic Hernia Studies
  • Medical Imaging and Pathology Studies
  • Tracheal and airway disorders
  • Lung Cancer Treatments and Mutations
  • Cardiac tumors and thrombi
  • Congenital Heart Disease Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Aortic Disease and Treatment Approaches
  • COVID-19 diagnosis using AI
  • Long-Term Effects of COVID-19
  • Acute Ischemic Stroke Management
  • Coronary Artery Anomalies
  • Soft tissue tumor case studies
  • Cancer Immunotherapy and Biomarkers
  • Atrial Fibrillation Management and Outcomes
  • Advanced X-ray and CT Imaging
  • Pneumothorax, Barotrauma, Emphysema
  • Ultrasound in Clinical Applications
  • Respiratory Support and Mechanisms
  • Infective Endocarditis Diagnosis and Management
  • Sarcoma Diagnosis and Treatment
  • IgG4-Related and Inflammatory Diseases

Hospital Sant Joan de Déu Barcelona
2020-2024

Hospital Del Mar
2015-2024

Hospital del Mar Research Institute
2020-2024

Municipal Institute for Medical Research
2024

Parc de Salut
2011-2022

Hospital Universitari de Girona Doctor Josep Trueta
2008-2009

Ospedale Policlinico San Martino
2008

University of Genoa
2006

Chronic thromboembolic pulmonary disease (CTEPD) consists of persistent vascular obstruction on imaging and involves long-term functional limitations, with or without chronic hypertension (CTEPH). The aim this study was to evaluate the incidence risk factors both defects CTEPH after hospitalization in patients COVID-19 PE during a 2-year follow-up.

10.1159/000536064 article EN Respiration 2024-01-01

Vertebral compression fractures (VCF) are common in COPD patients, with osteoporosis being the main cause. The clinical impact of VCF derives mostly from both pain and chest deformity, which may lead to ventilatory physical activity limitations. Surprisingly, consequences on quality outcomes hospital care poorly known.To assess these indicators patients hospitalized due a exacerbation (ECOPD) who also have VCF.Clinical characteristics were assessed two one-year periods, one retrospective...

10.2147/copd.s129213 article EN cc-by-nc International Journal of COPD 2017-06-01

Scimitar syndrome is a rare form of congenital heart disease (CHD) characterized by anomalous pulmonary venous drainage the right lung to inferior vena cava. We describe presentation, diagnosis, therapeutic management and long-term follow-up 10 pediatric patients with Syndrome.

10.1177/21501351241247512 article EN World Journal for Pediatric and Congenital Heart Surgery 2024-05-21

Signet-ring cell carcinoma is a rare and aggressive variant of mucinous adenocarcinoma. Only few cases gallbladder adenocarcinoma with signet-ring cells have been reported because this there lack knowledge about the behavior biology pathology.We present case 63-year-old Arab man He had an elective cholecystectomy refused chemotherapy. Two months later, small hepatic metastatic nodule was found, nine later he presented multiple metastases in liver, lymphatic nodes, both pleuras, peritoneum...

10.1186/1752-1947-5-458 article EN cc-by Journal of Medical Case Reports 2011-09-14

Approximately 50 % of malignant melanomas harbor activating point mutations in the BRAF gene. Typically, these result substitution amino acid valine at codon 600 gene, and 90–95 are either BRAFV600E or BRAFV600K. Specific inhibitors such as dabrafenib vemurafenib mainstays treatment patients with metastatic BRAF-mutant melanomas. The third most common mutation is V600R, which also leads to increased signaling. Although evidence exists about activity BRAFV600R mutation, have been...

10.1186/s13256-016-0953-0 article EN cc-by Journal of Medical Case Reports 2016-06-02

To compare clinical characteristics, outcomes, and resource consumption of patients with coronavirus disease 2019 (COVID-19) seasonal influenza requiring supplemental oxygen.Retrospective cohort study conducted at a tertiary-care hospital. Patients admitted because between 2017 2019, or COVID-19 March May 2020 oxygen were compared. Primary outcome: 30-day mortality. Secondary outcomes: 90-day mortality hospitalization costs. Attempted sample size to detect an 11% difference in was 187 per...

10.1093/cid/ciac314 article EN Clinical Infectious Diseases 2022-04-19

Abstract Immunotherapy has considerably improved clinical outcomes in different types of cancers but also been associated with the development myocarditis, especially that mediated by immune checkpoint inhibitors. To best our knowledge, these are first cases myocarditis after anti‐GD2 immunotherapy reported to date. We present two paediatric patients who, infusion, presented severe myocardial hypertrophy detected on echocardiography and confirmed cardiac magnetic resonance imaging. An...

10.1002/ehf2.14330 article EN cc-by-nc ESC Heart Failure 2023-03-07

Abstract The rapid spread of the severe acute respiratory syndrome coronavirus 2 led to a global overextension healthcare. Both Chest X-rays (CXR) and blood test have been demonstrated predictive value on Coronavirus Disease 2019 (COVID-19) diagnosis different prevalence scenarios. With objective improving accelerating COVID-19, multi modal prediction algorithm (MultiCOVID) based CXR was developed, discriminate between Heart Failure Non-COVID Pneumonia healthy (Control) patients. This...

10.1038/s41598-023-46126-8 article EN cc-by Scientific Reports 2023-10-31

10.1016/j.ultrasmedbio.2006.02.723 article EN Ultrasound in Medicine & Biology 2006-05-01

Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported multiple studies. However, inconsistent results incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controversy regarding the concept HPD.Consecutive patients treated nivolumab (N = 42) or docetaxel 37) were evaluated. HPD was quantified by applying three methods (tumor growth rate [TGR], tumor kinetics [TGK], Response...

10.1016/j.jtocrr.2020.100115 article EN cc-by-nc-nd JTO Clinical and Research Reports 2020-10-28
Coming Soon ...